SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-021988
Filing Date
2023-05-15
Accepted
2023-05-15 08:34:39
Documents
12
Period of Report
2023-05-15
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K rcus-20230515.htm   iXBRL 8-K 48750
  Complete submission text file 0000950170-23-021988.txt   161388

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rcus-20230515_pre.xml EX-101.PRE 9445
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rcus-20230515.xsd EX-101.SCH 2457
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rcus-20230515_lab.xml EX-101.LAB 12806
6 EXTRACTED XBRL INSTANCE DOCUMENT rcus-20230515_htm.xml XML 4523
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38419 | Film No.: 23918630
SIC: 2834 Pharmaceutical Preparations